🇻🇪 Country Profile

Venezuela

Pharmaceutical products reaching Venezuela

🇻🇪 $90.0M
All data from DGCIS India export records (fiscal year, April–March).
$90.0M
Scale
Venezuela's patients receive $90.0M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
93%
Medicine
Overwhelmingly finished medicines, drug formulations account for 93% of shipments.
Context
Part of India's pharmaceutical supply network across Americas.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Venezuela, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $83.6M (92.6%) Medicine Ingredients $2.8M (3.1%) Vaccines $2.6M (2.8%) Surgical & Hospital Supplies $1.2M (1.4%) Traditional & Herbal $0.06M (0.1%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Venezuela Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Venezuela: $12.7M across 31 filings (2011-2017).